Cost-effectiveness of clopidogrel in Mexico: A long term analysis

被引：0
|
作者：
Jerjes-Sanchez, C.
Trujillo, A.
Ramos, M. A.
Hernandez, I
Alvarado, R.
Cruz, A.
Rangel, F. J.
Morales, E.
机构：
[1] IMSS, Hosp Enfermedades Cardiovasc & Torax, Monterrey, Nuevo Leon, Mexico
[2] Hosp Gen Zona 57, Mexico City, DF, Mexico
[3] UMAE CM Raza, Mexico City, DF, Mexico
[4] Hosp Juarez Mexico, Mexico City, DF, Mexico
[5] ISSSTE Durango, Durango, Mexico
[6] Hosp PEMEX Norte, Mexico City, DF, Mexico
[7] Cardiometab Res Unit, Aguascalientes, Mexico
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63642-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A345 / A345
页数：1
相关论文
共 50 条
  • [11] Long-term reduction of cardiovascular events and cost-effectiveness of different statins and doses in Mexico
    Mino, D.
    Soto, H.
    Gomez, E.
    Parcero, J. J.
    Cortes, L.
    Zanela, O.
    Polanco, A. C.
    VALUE IN HEALTH, 2008, 11 (03) : A195 - A196
  • [12] Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden:: a long-term model based on the cure trial
    Lindgren, P
    Jönsson, B
    Yusuf, S
    JOURNAL OF INTERNAL MEDICINE, 2004, 255 (05) : 562 - 570
  • [13] The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden
    Lindgren, P
    Stenestrand, U
    Malmberg, K
    Jönsson, B
    CLINICAL THERAPEUTICS, 2005, 27 (01) : 100 - 110
  • [14] Cost-Effectiveness of Clopidogrel: Seeing through the Smoke
    Goldman, Lee
    Gaspoz, Jean-Michel
    MEDICAL DECISION MAKING, 2008, 28 (06) : 803 - 809
  • [15] Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico
    Arreola Ornelas, Hector
    Rosado Buzzo, Alfonso
    Garcia, Lourdes
    Dorantes Aguilar, Javier
    Contreras Hernandez, Iris
    Mould Quevedo, Joaquin F.
    REUMATOLOGIA CLINICA, 2012, 8 (03): : 120 - 127
  • [16] COST-EFFECTIVENESS ANALYSIS OF LIRAGLUTIDE FOR THE TREATMENT OF OBESITY IN MEXICO
    Valdez-Huerta, R.
    Moreno, D.
    Paladio Hernandez, J. A.
    VALUE IN HEALTH, 2022, 25 (07) : S350 - S350
  • [17] The cost-effectiveness of clopidogrel based on three trials
    Lindgren, P.
    Ringborg, A.
    Jonsson, B.
    EUROPEAN HEART JOURNAL, 2005, 26 : 367 - 367
  • [18] Short- and long-term cost-effectiveness analysis of adding clopidogrel to standard therapy in acute coronary syndrome patients in Spain
    Badia, X
    Bueno, H
    Juanatey, JRG
    Valentín, V
    Rubio, M
    REVISTA ESPANOLA DE CARDIOLOGIA, 2005, 58 (12): : 1385 - 1395
  • [19] Long-term cost-effectiveness of rimonabant in Germany
    Pirk, O.
    Hessel, F.
    Kotowa, W.
    Hertel, N.
    VALUE IN HEALTH, 2007, 10 (06) : A414 - A415
  • [20] 9301 cost-effectiveness of long-term therapy with clopidogrel following percutaneous coronary intervention:: A Swedish analysis of the CREDO-trial
    Ringborg, A
    Lindgren, P
    Jönsson, B
    VALUE IN HEALTH, 2005, 8 (03) : 253 - 253
12345